GW Pharma tops list of UK R&D spenders

Pharma is leading the way in R&D investment in the UK, with cannabis medicine specialist GW splurging almost 1,345% of its total revenue on research according to an analysis.

Sanofi Pasteur to develop COVID-19 vaccine with US governmen...

Sanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a US government department to develop a novel COVID-19 coronavirus vaccine.

UK biotech OMass raises £27.5m for GPCR drug discovery

Castor gifts access to data platform for non-profit Covid-19...

Chiesi starts rare diseases division, ahead of potential Fab...

Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy.

Blockbusters in waiting: drug launches to watch in 2020